in this study were differentiated from adipose-derived mesenchymal stem cells (ADSCs). The effects of growth factors were evaluated by measuring the proliferation and collagen secretion of fibroblasts to determine optimal growth factor concentrations.
Fibroblasts are one of the main components of pelvic floor tissue. They are important for the healing process of pelvic floor tissue defects. [3] In a previous study on the reconstruction of pelvic floor tissue defects, Ruiz-Zapata et al. [4, 5] found that basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), and vascular endothelial growth factor are expressed in the damaged area to promote angiogenesis and granulation tissue regeneration. In advanced defect repair, a large number of fibroblasts mature to secrete collagen, which facilitates wound healing and repair functions. [6] Therefore, the collagen secretion and proliferation of fibroblasts are important for defect healing. In this study, fibroblasts were induced from ADSCs. [7, 8] In studies on the effects of bFGF to promote fibroblast functions, bFGF concentrations vary from 0.005 to 2000 ng/ml, [2, [9] [10] [11] [12] with no defined optimal concentration. EGF is a widely used growth factor to promote the repair of skin fibroblasts. [13] In this study, we found that EGF plays a synergistic role with bFGF in promoting the proliferation of fibroblasts. It is difficult to detect the physiological effects of various growth factor concentrations around the pelvic floor ligament. Therefore, this study was designed to optimize the concentrations of combined bFGF and EGF to promote pelvic floor microenvironment stability.
This study was only a part of microenvironments' research of tissue engineering reconstruction of pelvic sacral ligament. ADSCs performed as original seed cells for the feature of low immunogenicity, widely source, high survival rate, and conducive to subsequent experiments in vivo; in addition, ADSCs could be differentiated to specific cells according to the demand of tissue engineering. In the whole tissue engineering reconstruction experiment, ADSCs were induced to differentiate into fibroblasts and smooth muscle cells, and the homology of the two kinds of cells was conducive to the development of cell culture in vitro and the transplantation of reconstruction of the sacral ligament of tissue engineering in the future. This article only introduced the experimental results of fibroblast growth microenvironment study.
Methods

Primary culture of ADSCs
Adipocytes were isolated from groin adipose tissue of Sprague-Dawley rats (8-10 weeks old). All procedures were approved by the Ethics Committee of our hospital. The adipose tissue was rinsed with phosphate-buffered saline (PBS) three times, visible blood vessels and fascial fibers were removed, [14] and the tissue was cut into 1 mm 3 pieces. Digestion was performed with 0.01% Type I collagenase at 37°C in a water bath for 30 min. The digestion was terminated by adding PBS (HyClone, Logan, Utah, USA) containing 10% fetal bovine serum (Gibco, Grand Island, New York, USA) and 1% antibiotics (100 U/ml penicillin/streptomycin) (Gibco). The cells were cultured at 37°C with 5% CO 2 . The medium was changed after 3 days and then every 3 days. The experimental protocol was approved by the Institutional Animal Care and Use Committee of Hospital (No. 2015-35).
Fibroblasts induced from ADSCs
According to the classic report, [14, 15] the fibroblasts could be induced by ADSCs cultured in the 20 ng/ml bFGF and 20 ng/ml EGF medium. The culture medium was replaced with fibroblast-inducing medium containing 20 ng/ml bFGF (Gibco) and 20 ng/ml EGF (Gibco), and then ADSCs were cultured to 40-50% confluence. [15, 16] Cells were cultured for another 2 weeks, and the medium was changed every 2-3 days. The cells were then identified by flow cytometry and immunohistochemistry.
Flow cytometric analysis
The third passage of ADSCs was identified by flow cytometric analysis of CD29, CD44, CD90, and CD45 (Abcam, San Francisco, USA). [14] Suspensions of ADSCs were prepared at 1 × 10 6 cells/ml. One hundred microliters of cell suspension were stained with 20 μl rat CD29-FITC (1:100, ab93759), CD44-FITC (1:100, ab157107), CD45-FITC (1:100, ab10558), or CD90-FITC 
Proliferation assay
The effects of the growth factors on fibroblast proliferation were determined by Cell Counting Kit-8 (CCK-8, MedChem Express, New Jersey, USA). [16] Fibroblasts were seeded at 2 × 10 2 cells/ml in 96-well plates and treated with various concentrations and combinations of growth factors for 1-7 days. The treatments were as follows: (i) bFGF at 0, 1, 10, and 100 ng/ml, (ii) EGF at 0, 1, 10, and 100 ng/ml, and (iii) both bFGF and EGF at 0, 1, 10, and 100 ng/ml each. The medium was changed every day. A CCK-8 assay was performed each day up to the 7 th day. All experiments were repeated three times.
Reverse transcription quantitative real-time polymerase chain reaction of Type I and III collagen mRNAs
ADSCs and fibroblasts were cultured in six-well plates. They were cultured in normal medium and medium of the various groups of growth factors for 7 days. Total RNA of the cells was extracted before and after induction from ADSCs, and total RNA of fibroblasts was extracted at the 7 th day. RNA samples were reverse transcribed, and cDNA of the following genes was amplified by reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR): Type I collagen (Col-I), Type III collagen (Col-III), and β-actin as the reference gene. Primer sequences [ Table 1 ] were designed using Primer Premier (version 5.0, PREMIER Biosoft, California, USA). [17] PCR samples were subjected to agarose gel electrophoresis and imaging. Expression values were analyzed using Adobe Photoshop. The experiments were repeated three times.
Immunohistochemistry of ADSCs
ADSCs were cultured on glass coverslips in six-well plates for 7 days. The cells were washed with PBS twice and then fixed in 4% paraformaldehyde. The samples were analyzed by immunohistochemistry of CD29, CD44, CD90, and CD45 and observed by light microscopy. [14] Fibroblasts were also cultured on glass coverslips in six-well plates for 7 days and then analyzed by immunohistochemistry of fibroblast-specific protein-1 (FSP-1).
Statistical analysis
All data are presented as mean ± standard deviation. Statistical analysis was performed with SPSS software (version 19.0, SPSS Inc., Chicago, IL, USA) and GraphPad Prism (version 6.0, GraphPad, Inc., La Jolla, California, USA) using nonparametric and ordinary one-way analysis of variance and multiple t-test. Values of P < 0.05 were accepted as statistically significant.
results
Rat abdominal fat tissue-derived ADSCs isolation and immunophenotyping
ADSCs were derived successfully from rat pelvic tissue [ Figure 1a ]. After 3 days of primary culture, the ADSCs morphology became stable with an irregular polygonal shape [ Figure 1c ]. ADSCs grew markedly fast from day 4. Immunocytochemistry revealed expression of specific surface markers of ADSCs [ Figure 1b ]. ADSCs were positive for CD29, CD44, and CD90 and negative for CD45. Flow cytometry results showed the typical immunophenotype of ADSCs with expression rates of CD29, CD44, CD90, and CD45 at 99.39%, 94.6%, 89.6%, and 0.15%, respectively [ Figure 1d ]. 
Identification of ADSCs-induced fibroblasts
Basic fibroblast growth factor and epidermal growth factor promote cell proliferation of ADSCs-induced fibroblasts at an optimized concentration
The growth curves showed that cells proliferated in culture, and there were significant differences between the groups containing growth factors and groups without growth factors [ Figure 3 ]. In groups containing bFGF, the growth of fibroblasts was enhanced markedly by 10 and 100 ng/ml bFGF, and the number of cells was increased dramatically [ Figure 3a ]. However, in the 100 ng/ml bFGF group, fibroblast numbers did not increase further, indicating that 10 ng/ml bFGF was a more suitable culture condition to maintain and promote the proliferation of fibroblasts (0 ng/ml, 1.710 ± 0.205; 1 ng/ml, 2.318 ± 0.260; 10 ng/ml, 2.899 ± 0.1057; and 100 ng/ml, 2.360 ± 0.2001; t 0-1 = 3.1806, P 0-1 = 0.0335, t 1-10 = 3.586, P 1-10 = 0.0230, t 10-100 = 4.127, and P 10-100 = 0.0140; F = 17.64, P = 0.0007). In groups containing 10 ng/ml EGF, the growth of fibroblasts was enhanced markedly, and the number of cells was increased dramatically [ Figure 3b ] compared with the 100 ng/ml EGF group, indicating that 10 ng/ml EGF was a more suitable culture condition to maintain and promote the proliferation of fibroblasts (0 ng/ml, 1.667 ± 0.232; 1 ng/ml, 2.203 ± 0.208; 10 ng/ml, 2.697 ± 0.126; 2.455 ± 0.054; t 0-1 = 2.9795, P 0-1 = 0.0408, t 1-10 = 3.518, P 1-10 = 0.0240, t 10-100 = 3.057, and P 10-100 = 0.0370; F = 11.66, P = 0.0027). The combination of 10 ng/ml bFGF and 10 ng/ml EGF had the optimal effect on promoting fibroblast proliferation among the various concentrations with the number of cells increased dramatically (0 ng/ml, 1.703 ± 0.254; 1 ng/ml, 2.550 ± 0.244; 10 ng/ml, 3.011 ± 0.102; and 100 ng/ml, 2.620 ± 0.115; t 0-1 = 4.165, P 0-1 = 0.0140, t 1-10 = 3.019, P 1-10 = 0.0390, t 10-100 = 4.405, and P 10-100 = 0.0110; F = 24.64, P = 0.0002; Figure 3c ).
Type I and III collagens expression in ADSCs-induced fibroblasts under the optimized concentration of combined basic fibroblast growth factor and epidermal growth factor treatment
To evaluate the effects of the various experimental conditions of bFGF and EGF on the capacity of the fibroblastic cells to express Col-I and Col-III, RT-qPCR was used to measure the mRNA levels of Col-I and Col-III. As an effect of the various concentrations of bFGF and EGF, the expression of Col-I and Col-III in fibroblasts was significantly different [ Figure 4a ]. In the 10 ng/ml bFGF group, expression of Col-I was higher than that in the other two bFGF groups (0.699 ± 0.074 vs. 1.608 ± 0.114 vs. 1.500 ± 0.015, F = 79.13, P = 0.0025; Figure 4b ). Among the EGF groups, there was slightly higher expression of Col-I in the 10 ng/ml group than that in the other concentrations (0.219 ± 0.018 vs. 0.892 ± 0.022 vs. 0.350 ± 0.048, F = 245.50, P = 0.0005; Figure 4b ). The Col-I mRNA expression of group 10 ng/ml bFGF mixed with 10 ng/ml EGF was the highest in the double growth factor groups (0.858 ± 0.023 vs. 1.883 ± 0.099 vs. 1.840 ± 0.089, F = 110.50, P = 0.0015; Figure 4b ) and also the highest among all 10 ng/ml growth factor groups as well (1.608 ± 0.114 vs. 0.892 ± 0.022 vs. 1.883 ± 0.099, F = 67.45, P = 0.0032; Figure 4b ). In addition, the expression of Col-I in the 1 ng/ml mixed growth factors' group was obviously higher than the OD values at 490 nm of fibroblasts were shown. Only the OD value in the 10 ng/ml bFGF group (red curve) was increased significantly (day 6: 0.754 ± 0.114, 1.069 ± 0.155, 1.855 ± 0.166, 1.216 ± 0.170, t = 2.835, P = 0.0470, t = 5.994, P = 0.0038, t = 4.658, P = 0.0096; F = 27.52, *P = 0.0001; day 7: 1.710 ± 0.205, 2.318 ± 0.260, 2.899 ± 0.106, 2.360 ± 0.200, t = 3.1806, P = 0.0335, t = 3.586, P = 0.0230, t = 4.127, P = 0.0140, t = 3.586, P = 0.0340; F = 17.64, † P = 0.0007). (b) Effect of EGF on fibroblasts. Only the OD value in the 10 ng/ml EGF group (red curve) was increased significantly during the past 2 days (1.667 ± 0.232, 2.203 ± 0.208, 2.697 ± 0.166, and 2.343 ± 0.252; t = 2.9795, P = 0.0408; t = 3.215, P = 0.0324; and t = 2.031, P = 0.1100; F = 11.66, *P = 0.0027). (c) Effects of bFGF mixed with EGF on fibroblasts. The OD value was increased obviously in the intermediate concentration group (red curve) (day 6: 1.204 ± 0.100, 2.149 ± 0.170, 2.909 ± 0.182, and 2.330 ± 0.262; t = 8.590, P = 0.0011; t = 5.678, P = 0.0047; and t = 3.457, P = 0.0250; F = 45.15, *P < 0.0001; day 7: 1.703 ± 0.254, 2.550 ± 0.244, 3.011 ± 0.102, and 2.620 ± 0.115; t = 4.165, P = 0.0140; t = 3. In the bFGF group, the Col-III expression of concentration of 10 ng/ml was higher than that in the 1 ng/ml bFGF group (0.649 ± 0.048, 1.686 ± 0.045, and 1.612 ± 0.080, F = 187.20, *P = 0.0007) but was not different compared with the 100 ng/ml bFGF group. In the EGF groups, only the expression of Col-III in the 10 ng/ml group was highest (0.378 ± 0.093, 1.457 ± 0.023, and 0.490 ± 0.055, F = 173.1, † P = 0.0008). Col-III expression in the group of bFGF mixed with EGF was the highest at 10 ng/ml (1.104 ± 0.110, 1.894 ± 0.121, and 1.801 ± 0.098, F = 30.78, ‡ P = 0.010). The Col-III expression at 1 ng/ml of two growth factors' group was still higher than that in the 1 ng/ml bFGF and EGF alone groups (0.649 ± 0.048, 0.378 ± 0.093, and 1. Figure 4b ). The increasing trend of Col-III expression in the various concentration groups was similar to that of Col-I expression. In the 10 ng/ml bFGF group, Col-III expression was higher than in the 1 ng/ml bFGF group and 100 ng/ml bFGF group (0.649 ± 0.048 vs. 1.686 ± 0.045 vs. 1.612 ± 0.080, F = 187.20, P = 0.0007; Figure 4c ) but was not different compared with the 100 ng/ml bFGF group. In EGF groups, there was obviously higher expression of Col-III in the 10 ng/ml group than that in the other concentrations (0.378 ± 0.093 vs. 1.457 ± 0.023 vs. 0.490 ± 0.055, F = 173.10, P = 0.0008; Figure 4c ). Col-III expression in the group of bFGF mixed with EGF was the highest at 10 ng/ml each (1.104 ± 0.110 vs. 1.894 ± 0.121 vs. 1.801 ± 0.098, F = 30.78, P = 0.0100; 1.686 ± 0.045 vs. 1.457 ± 0.023 vs. 1.894 ± 0.121, F = 16.67, P = 0.0237; Figure 4c ), and Col-III expression at 1 ng/ml was still higher than that in the 1 ng/ml bFGF or EGF alone groups (0.649 ± 0.048 vs. 0.378 ± 0.093 vs. 1.104 ± 0.110, F = 35.05, P = 0.0083; Figure 4c ). The ratio of Col-I expression to Col-III expression of group with10 ng/ml bFGF mixed with EGF was just less than one and compared with other groups with no significant difference.
dIscussIon
In this study, we found that the cell proliferation did not have a linear relationship with the concentrations of bFGF and EGF. However, the most effective concentration was 10 ng/ml. bFGF significantly promoted cell proliferation and collagen expression of fibroblasts. EGF mildly promoted fibroblast proliferation and had a slight effect on collagen expression. When bFGF was combined with EGF, we found significant promotion of fibroblast proliferation and expression of collagens. Therefore, bFGF plays more important roles in expression of Col-I and Col-III. This study revealed that the combined use of bFGF/EGF significantly improved fibroblast proliferation and differentiation.
Optimized concentrations of growth factors can simulate a microenvironment in tissue engineering, which is closer to the microenvironment in vivo. Growth factors such as bFGF are present in the microenvironment of tissue repair after tissue damage and play an important role in repair of the pelvic ligament. bFGF and EGF are the most widely studied growth factors. [17, 18] bFGF stimulates the proliferation of fibroblasts. Moreover, Wang et al. [19] showed that bFGF promotes collagens' expression. EGF has been shown to affect cell proliferation and collagen expression in wound repair and reconstruction of tissue. [13, 17] For different organs, there may be different kinds of EGF receptors with different effects on cell proliferation and protein expression. [20] [21] [22] Many studies [22] [23] [24] have focused on how growth factors mediate signaling pathways that affect cell proliferation and protein expression, while there were few studies on the physiological concentrations of growth factors. Accumulating studies have focused on new materials and various growth factors to make the microenvironment of seed cells in tissue engineering closer to the microenvironment in vivo. Therefore, construction of the microenvironment in tissue engineering in vitro with optimal concentrations of growth factors is important. The optimized concentration of combined bFGF and EGF promoted the proliferation of fibroblasts, which are the main cells in repair of pelvic ligaments, contributing to efficient construction of tissue with seed cells for tissue engineering.
Col-I and III play a very important role in the repair of defects in female pelvic floor tissue, which obviously influence the elasticity and toughness of ligaments in pelvic floor tissue. [25] For ideal repair of pelvic floor ligament tissue, high expression of Col-I will lead to more tenacity, and high expression of Col-III will result in greater elasticity of the ligament. [26] Both Col-I and Col-III increased in the early time after pelvic floor damaged in a very short time, while the flawed tissue stimulated and promoted the regeneration of surroundings which might gather a lot of inflammatory cells with various kinds of growth factors. However, the collagens would decrease in the next period, in which inflammatory cytokines stimulated cells to release a large amount of proteases to the extracellular matrix. Some proteases, such as fibrinolytic enzyme, kinase releasing enzyme, and matrix metalloproteinases, could inhibit the formation of collagen or promote the degradation of collagen obviously. The final result was collagens reduced in the sacrospinous ligament of patients with pelvic organ prolapse disease, and what was more significant for Col-III. The ratio of Col-I to Col-III was calculated and compared in women with pelvic floor dysfunction or not and found that the ratio of Col-I to Col-III increased. [26] [27] [28] [29] [30] Therefore, it was very important to replenish collagen in the process of pelvic floor tissue repair. By supplementing Col-I and III exogenously and resisting the degradation of local tissues, the collagen content of local tissues was improved, and local tissue mechanical properties were enhanced. In this study, certain kinds of growth factors induce fibroblasts to secrete of Col-I and Col-III to the microenvironment, which might improve the efficiency of tissue engineering. [31] By secreting collagens, surrounding cells can regenerate to repair tissue defects with a better microenvironment. The optimized concentration of combined bFGF and EGF increases the expression of Col-I and Col-III effectively. Maintaining the optimal concentrations of bFGF and EGF in culture might contribute to the stability of the tissue engineering microenvironment.
At the early stage of growth factor treatments, the various concentrations did not have obviously different effects on cell proliferation, and the small growth curve may be the result of the excessively low initial densities of cells. The effects on cell proliferation by treatment with 10 ng/ml bFGF, EGF, and both bFGF and EGF at the 7 th day were similar, which might have been caused by contact inhibition of cells, and the cell densities of the three groups reached their maximum in 96-well plates. Therefore, there was no significant difference on the optical density value of the 7 th day of fibroblasts among different growth factor groups.
The mRNA levels of Col-I and Col-III in cells treated with 10 ng/ml bFGF, EGF, and both bFGF and EGF were similar, which might be caused by cells reaching their maximum densities in six-well plates. In addition, the reason for the significant increase of collagen expression in the 10 ng/ml EGF group may be that the number of cells was highest at this concentration. Because cell activity in vivo is regulated by interactions of several kinds of growth factors from the microenvironment, the interactions of these factors need further study at molecular and cellular levels.
In conclusion, the effects of bFGF and EGF on cell proliferation and protein expression are not stronger as their concentrations increased linearly. The optimal concentration of both bFGF and EGF for cell proliferation and collagen expression of fibroblasts was 10 ng/ml at which fibroblasts grew faster and secreted more Col-I and Col-III into the extracellular matrix, which might contribute to microenvironment stability. In tissue engineering for pelvic floor reconstruction in vitro, the effective concentrations and combination of bFGF and EGF can make the microenvironment more efficient and advantageous. The optimal concentration of growth factors should be considered in research to rebuild or repair organs. 
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